Denali Therapeutics Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 3,030 | 0.0% | 184,238 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 4,408 | 0.0% | 315,102 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 3,509 | 0.0% | 258,132 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 4,250 | 0.0% | 208,521 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 6,025 | 0.0% | 206,819 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 4,000 | 0.0% | 172,281 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 3,060 | 0.0% | 149,116 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 2,172 | 0.0% | 101,223 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 2,339 | 0.0% | 113,398 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 3,510 | 0.0% | 118,949 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 2,654 | 0.0% | 115,183 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 3,139 | 0.0% | 112,059 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 3,285 | 0.0% | 110,257 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 3,504 | 0.0% | 120,287 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 3,817 | 0.0% | 118,085 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 2,086 | 0.0% | 46,496 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 2,368 | 0.0% | 46,935 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 4,027 | 0.0% | 51,333 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 2,058 | 0.0% | 36,046 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 3,205 | 0.0% | 38,264 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 1,331 | 0.0% | 37,147 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 905 | 0.0% | 38,198 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 586 | 0.0% | 33,471 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 530 | 0.0% | 30,444 | 12/31/2019 |